ClinicalTrials.govpublic full text
Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer
hormone receptor positive malignant neoplasm of breast, human epidermal growth factor 2 negative carcinoma of breast, estrogen receptor positive breast cancer, progesterone receptor positive tumor, metastatic breast cancer, palbociclib, tamoxifen, cdk4/6 inhibitor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 825595
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.